---
title: Default HubSpot Blog
---

[![Noble-Life-Sciences-Logo-1-1](https://content.noblelifesci.com/hubfs/Noble-Life-Sciences-Logo-1-1.png) ![Noble-Life-Sciences-Logo-1-1](https://content.noblelifesci.com/hubfs/Noble-Life-Sciences-Logo-1-1.png)](https://noblelifesci.com/)

- [Home](https://noblelifesci.com/)
- [Drugs](https://noblelifesci.com/therapeutics/) 
    - [Oncology](https://noblelifesci.com/therapeutics/oncology-cro/)
    - [Infectious Diseases](https://noblelifesci.com/therapeutics/infectious-diseases/)
    - [Diabetes](https://noblelifesci.com/therapeutics/diabetes/)
- [Devices](https://noblelifesci.com/devices/) 
    - [Cardiovascular](https://noblelifesci.com/devices/cardiovascular-devices/)
    - [Orthopedics](https://noblelifesci.com/devices/orthopedics/)
    - [Trauma](https://noblelifesci.com/devices/trauma/)
    - [Wound Healing](https://noblelifesci.com/devices/wound-healing/)
- [Cell & Gene](https://noblelifesci.com/cell-gene-therapy/) 
    - [Biodistribution & Shedding](https://noblelifesci.com/cell-gene-therapy/biodistribution-shedding/)
    - [Toxicology](https://noblelifesci.com/cell-gene-therapy/toxicology-services/)
    - [Flow Cytometry](https://noblelifesci.com/cell-gene-therapy/flow-cytometry/)
    - [Immunoassays](https://noblelifesci.com/cell-gene-therapy/immunoassays/)
    - [Efficacy](https://noblelifesci.com/cell-gene-therapy/efficacy/)
- [About](https://noblelifesci.com/about-noble/) 
    - [Mission](https://noblelifesci.com/about-noble/mission-vision/)
    - [Management Team](https://noblelifesci.com/about-noble/management-team/)
    - [Compliance](https://noblelifesci.com/about-noble/compliance/)
    - [Facilities](https://noblelifesci.com/about-noble/facilities/)
    - [Careers](https://noblelifesci.com/careers/)
    - [Blog](https://noblelifesci.com/about-noble/blog/)
- [Resources](https://noblelifesci.com/resources/)
- [Contact Us](https://noblelifesci.com/contact/)

# Default HubSpot Blog

## [Immuno-oncology Therapeutics](https://content.noblelifesci.com/blog/immuno-oncology-therapeutics)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  August 17th, 2022   |Categories:

[Read More](https://content.noblelifesci.com/blog/immuno-oncology-therapeutics)

Comments Off

## [Immunophenotyping of Tumor-Infiltrating Immune Cells in Mouse Syngeneic Tumor Models Using Multi-Color Flow Cytometry Assays](https://content.noblelifesci.com/blog/immunophenotyping-of-tumor-infiltrating-immune-cells-in-mouse-syngeneic-tumor-models-using-multi-color-flow-cytometry-assays)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  August 9th, 2022   |Categories:

[Read More](https://content.noblelifesci.com/blog/immunophenotyping-of-tumor-infiltrating-immune-cells-in-mouse-syngeneic-tumor-models-using-multi-color-flow-cytometry-assays)

Comments Off

## [Toxicology Study Design Considerations](https://content.noblelifesci.com/blog/toxicology-study-design-considerations)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  March 20th, 2022   |Categories:

[Read More](https://content.noblelifesci.com/blog/toxicology-study-design-considerations)

Comments Off

## [Preclinical Toxicology Considerations for Successful IND Application](https://content.noblelifesci.com/blog/preclinical-toxicology-considerations-for-successful-ind-application)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  March 20th, 2022   |Categories:

[Read More](https://content.noblelifesci.com/blog/preclinical-toxicology-considerations-for-successful-ind-application)

Comments Off

## [Noble Life Sciences Welcomes Rigoberto Sanchez, Associate Director, Quality Assurance.](https://content.noblelifesci.com/blog/noble-life-sciences-welcomes-rigoberto-sanchez-quality-assurance-manager)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  October 3rd, 2021   |Categories:

[Read More](https://content.noblelifesci.com/blog/noble-life-sciences-welcomes-rigoberto-sanchez-quality-assurance-manager)

Comments Off

## [Acute and Repeated-Dose Toxicity Studies](https://content.noblelifesci.com/blog/acute-and-repeated-dose-toxicity-studies)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  October 3rd, 2021   |Categories:

[Read More](https://content.noblelifesci.com/blog/acute-and-repeated-dose-toxicity-studies)

Comments Off

## [IND-enabling Toxicology Studies](https://content.noblelifesci.com/blog/ind-enabling-toxicology-studies)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  September 29th, 2021   |Categories:

[Read More](https://content.noblelifesci.com/blog/ind-enabling-toxicology-studies)

Comments Off

## [Viral Quantification Methods](https://content.noblelifesci.com/blog/viral-quantification-methods)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  August 16th, 2021   |Categories:

[Read More](https://content.noblelifesci.com/blog/viral-quantification-methods)

Comments Off

## [Evaluating Agents for Sepsis Treatment](https://content.noblelifesci.com/blog/evaluating-agents-for-sepsis-treatment)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  August 1st, 2021   |Categories:

[Read More](https://content.noblelifesci.com/blog/evaluating-agents-for-sepsis-treatment)

Comments Off

## [COVID-19 Research: Studying SARS CoV-2 Variants of Concern](https://content.noblelifesci.com/blog/covid-19-research-studying-sars-cov-2-variants-of-concern)

By [Noble Life Sciences](https://content.noblelifesci.com/blog/author/noble-life-sciences) |  August 1st, 2021   |Categories:

[Read More](https://content.noblelifesci.com/blog/covid-19-research-studying-sars-cov-2-variants-of-concern)

Comments Off

[1](https://content.noblelifesci.com/blog/page/1) [2](https://content.noblelifesci.com/blog/page/2)

[Next](https://content.noblelifesci.com/blog/page/2)

### Recent Posts

### Categories

Copyright © 2018 Noble Life Sciences, Inc. All Rights Reserved.

[LinkedIn](https://www.linkedin.com/company/1572992/) [Twitter](https://twitter.com/LifeNoble)